Gagnon Securities’s Celgene Corp CELG Stock Holding History

Gagnon Securities’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-1,966	Closed	-$205K	–	99
2017 Q4	$205K	Hold	1,966	–	–	0.07%	80
2017 Q3	$287K	Sell	1,966 -2	-0.1%	-$272	0.11%	73
2017 Q2	$256	Sell	1,968 -4	-0.2%	-$490	0.07%	71
2017 Q1	$245K	Sell	1,972 -3	-0.2%	-$359	0.11%	80
2016 Q4	$229K	Hold	1,975	–	–	0.1%	81
2016 Q3	$206K	Buy	+1,975	New	+$214K	0.09%	85
2016 Q2	–	Sell	-2,008	Closed	-$201K	–	102
2016 Q1	$201K	Hold	2,008	–	–	0.1%	76
2015 Q4	$240K	Buy	2,008 +5	+0.2%	+$578	0.11%	73
2015 Q3	$217K	Hold	2,003	–	–	0.11%	69
2015 Q2	$232K	Hold	2,003	–	–	0.09%	74
2015 Q1	$231K	Sell	2,003 -25	-1%	-$2.99K	0.08%	79
2014 Q4	$227K	Buy	+2,028	New	+$214K	0.07%	77

Other funds holding CELG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Gagnon Securities's CELG Position: Q1 2018 in Review

Gagnon Securities sold out of Celgene Corp (CELG) in Q1 2018, closing a stake of 1,966 shares — an estimated $205K sold.

Gagnon Securities first reported a position in CELG in Q4 2014 and held it in 12 quarters. The position peaked at $287K in Q3 2017. 1,397 funds tracked by Wall St. Rank hold CELG as of Q1 2018.

Gagnon Securities reported no remaining Celgene Corp position as of Q1 2018 after selling out during the quarter.
Gagnon Securities sold 1,966 Celgene Corp shares in Q1 2018, an estimated $205K.
Gagnon Securities first reported a position in Celgene Corp in Q4 2014 and held it in 12 quarters.
Gagnon Securities's Celgene Corp position peaked at $287K in Q3 2017.
1,397 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2018.

Based on Gagnon Securities's 13F filing for Q1 2018, filed 9 May 2018.